Review on t(9;15)(p13;q24) PAX5/GOLGA6A, with data on clinics, and the genes implicated.
Epidemiology
One case to date, a 21-year-old male patient with a CD10+ (B-II, common) ALL (Coyaud et al., 2010) .
Prognosis
No data.
Cytogenetics

Cytogenetics morphological
There were additional numerial anomalies (+5, +21). Lineage-specific transcription factor; recognizes the concensus recognition sequence GNCCANTGAAGCGTGAC, where N is any nucleotide. Involved in B-cell differentiation. Entry of common lymphoid progenitors into the B cell lineage depends on E2A, EBF1, and PAX5; activates B-cell specific genes and repress genes involved in other lineage commitments. Activates the surface cell receptor CD19 and repress FLT3. Pax5 physically interacts with the RAG1/RAG2 complex, and removes the inhibitory signal of the lysine-9-methylated histone H3, and induces V-to-DJ rearrangements. Genes repressed by PAX5 expression in early B cells are restored in their function in mature B cells and plasma cells, and PAX5 repressed (Fuxa et al., 2004; Johnson et al., 2004; Zhang et al., 2006; Cobaleda et al., 2007; Medvedovic et al., 2011) .
Genes involved and proteins
PAX5
GOLGA6A
Location 15q24.1 Protein 693 amino acids (aa); contains a coiled coil domain (aa 14-611), with 11 leucine zipper motifs (aa 360-430). Member of the golgin family of proteins, localizes to the Golgi apparatus. Its function is poorly known (Gilles et al., 2000) .
Result of the chromosomal anomaly
Hybrid gene
Description
Fusion of PAX5 exon 6 to GOLGA6A exon 3.
Fusion protein
Description 887 amino acids. The predicted fusion protein contains the DNA binding paired domain, the octapeptide, and the homeodomain of PAX5 and part of the coiled coil domain of GOLGA6A.
